CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
Onconova Therapeutics, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drug candidates to treat cancer. The companys clinical-stage product candidates include Rigosertib IV, which is in Phase III cli...Show all
Company (IPO / Went public)
Phone: 267-759-3680
375 Pheasant Run
Newtown, 18940
Pennsylvania, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Onconova Therapeutics | $165.6M | Jul 25, 2013 |
| KAI Pharmaceuticals | $63M | Apr 11, 2012 |
| MacuSight | $0M | Oct 27, 2019 |
| See all 17 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Stable aqueous formulation of (e)-4-carboxystyryl-4-chlorobenzyl sulfone | May 15, 2015 | Jul 25, 2017 | Patent |
| Stable aqueous formulation of (e)-4-carboxystyryl-4-chlorobenzyl sulfone | Mar 24, 2011 | Jun 23, 2015 | Patent |
| Compositions and methods for prevention and treatment of wounds | Mar 24, 2011 | Jun 02, 2015 | Patent |
| Treatment of proliferative disorders with amino-substituted (e)-2,6- dialkoxystyryl 4-substituted benzylsulfones | Jul 14, 2009 | Dec 04, 2012 | Patent |
| Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions | Sep 14, 2007 | Sep 25, 2012 | Patent |
